ADVB (STOCKS)

    Advanced Biomed Inc. Common Stock

    $4.320000
    +0.110000 (+2.61%)
    Prev close: $4.210000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Xiaomin Chen
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $7.37M
    Employees
    31
    P/E (TTM)
    28.27
    P/B (TTM)
    21.59
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Nonoperating Income/Loss $8.02M
    Operating Expenses $3.39M
    Depreciation and Amortization $320.33K
    Research and Development $975.26K
    Other Operating Expenses $2.09M
    Income/Loss From Continuing Operations After Tax $4.63M
    Income/Loss From Continuing Operations Before Tax $4.63M
    Net Income/Loss $5.28M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent $5.28M
    Net Income/Loss Available To Common Stockholders, Basic $5.28M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share $2.29
    Diluted Earnings Per Share $2.29
    Basic Average Shares 64,082,812
    Diluted Average Shares 64,082,812
    Assets $10.65M
    Current Assets $10.53M
    Prepaid Expenses $1.92M
    Other Current Assets $8.60M
    Noncurrent Assets $120.02K
    Fixed Assets $87.28K
    Other Non-current Assets $32.74K
    Liabilities $1.44M
    Current Liabilities $1.43M
    Accounts Payable $377.26K
    Other Current Liabilities $1.05M
    Noncurrent Liabilities $10.90K
    Equity $9.21M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $9.21M
    Liabilities And Equity $10.65M
    Net Cash Flow From Operating Activities -$2.91M
    Net Cash Flow From Operating Activities, Continuing -$399.54K
    Net Cash Flow From Investing Activities -$36.09K
    Net Cash Flow From Investing Activities, Continuing -$36.09K
    Net Cash Flow From Financing Activities $265.75K
    Net Cash Flow From Financing Activities, Continuing -$41.33K
    Exchange Gains/Losses -$71.48K
    Net Cash Flow -$2.75M
    Net Cash Flow, Continuing -$476.96K
    Comprehensive Income/Loss $4.83M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent $4.83M
    Other Comprehensive Income/Loss $4.83M